US Patents With Foreign Priority to India Patent: 2111/CHE/2009
✉ Email this page to a colleague
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primus Pharms | SERNIVO | betamethasone dipropionate | SPRAY;TOPICAL | 208079-001 | Feb 5, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF PLAQUE PSORIASIS | |||
| Primus Pharms | IMPOYZ | clobetasol propionate | CREAM;TOPICAL | 209483-001 | Nov 28, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER | |||
| Primus Pharms | SERNIVO | betamethasone dipropionate | SPRAY;TOPICAL | 208079-001 | Feb 5, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF PLAQUE PSORIASIS | |||
| Primus Pharms | SERNIVO | betamethasone dipropionate | SPRAY;TOPICAL | 208079-001 | Feb 5, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF PLAQUE PSORIASIS | |||
| Primus Pharms | SERNIVO | betamethasone dipropionate | SPRAY;TOPICAL | 208079-001 | Feb 5, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF PLAQUE PSORIASIS | |||
| Primus Pharms | SERNIVO | betamethasone dipropionate | SPRAY;TOPICAL | 208079-001 | Feb 5, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF PLAQUE PSORIASIS | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use |
